Cargando…
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
While existing remedies failed to fully address the consequences of heart failure, stem cell therapy has been introduced as a promising approach. The present review is a comprehensive appraisal of the impacts of using mesenchymal stem cells (MSCs) in clinical trials mainly conducted on ischemic card...
Autores principales: | Razeghian-Jahromi, Iman, Matta, Anthony G., Canitrot, Ronan, Zibaeenezhad, Mohammad Javad, Razmkhah, Mahboobeh, Safari, Anahid, Nader, Vanessa, Roncalli, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220796/ https://www.ncbi.nlm.nih.gov/pubmed/34162424 http://dx.doi.org/10.1186/s13287-021-02443-1 |
Ejemplares similares
-
Is It All About Endothelial Dysfunction and Thrombosis Formation? The
Secret of COVID-19
por: Elyaspour, Zahra, et al.
Publicado: (2021) -
Immune system and atherosclerosis: Hostile or friendly
relationship
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2022) -
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2020) -
Mesenchymal stem cells: amazing remedies for bone and cartilage defects
por: Kangari, Parisa, et al.
Publicado: (2020) -
Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction
por: Safari, Anahid, et al.
Publicado: (2021)